Veracyte Inc (VCYT)
20.35
+0.16
(+0.79%)
USD |
NASDAQ |
May 03, 16:00
20.35
0.00 (0.00%)
After-Hours: 20:00
Veracyte Research and Development Expense (Quarterly): 18.67M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 18.67M |
| September 30, 2023 | 13.32M |
| June 30, 2023 | 12.54M |
| March 31, 2023 | 12.77M |
| December 31, 2022 | 11.29M |
| September 30, 2022 | 10.77M |
| June 30, 2022 | 9.377M |
| March 31, 2022 | 9.166M |
| December 31, 2021 | 10.25M |
| September 30, 2021 | 8.006M |
| June 30, 2021 | 6.249M |
| March 31, 2021 | 5.336M |
| December 31, 2020 | 13.56M |
| September 30, 2020 | 1.039M |
| June 30, 2020 | 4.169M |
| March 31, 2020 | 4.407M |
| December 31, 2019 | 4.443M |
| September 30, 2019 | 3.643M |
| June 30, 2019 | 0.789M |
| March 31, 2019 | 3.435M |
| December 31, 2018 | 3.125M |
| September 30, 2018 | 3.419M |
| June 30, 2018 | 4.601M |
| Date | Value |
|---|---|
| March 31, 2018 | 3.675M |
| December 31, 2017 | 10.45M |
| September 30, 2017 | 0.847M |
| June 30, 2017 | 1.086M |
| March 31, 2017 | 1.497M |
| December 31, 2016 | 10.47M |
| September 30, 2016 | 1.586M |
| June 30, 2016 | 2.185M |
| March 31, 2016 | 1.493M |
| December 31, 2015 | 0.891M |
| September 30, 2015 | 1.714M |
| June 30, 2015 | 1.269M |
| March 31, 2015 | 1.109M |
| December 31, 2014 | 1.47M |
| September 30, 2014 | 0.969M |
| June 30, 2014 | 1.099M |
| March 31, 2014 | 0.943M |
| December 31, 2013 | 0.737M |
| September 30, 2013 | 1.043M |
| June 30, 2013 | 0.887M |
| March 31, 2013 | 2.01M |
| December 31, 2012 | 1.721M |
| September 30, 2012 | 1.729M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.789M
Minimum
Jun 2019
18.67M
Maximum
Dec 2023
8.411M
Average
9.166M
Median
Mar 2022
Research and Development Expense (Quarterly) Benchmarks
| Fonar Corp | 0.416M |
| XWELL Inc | -- |
| ProPhase Labs Inc | 0.274M |
| Applied DNA Sciences Inc | 0.9358M |
| OncoCyte Corp | 2.547M |